drugset / Trial / NCT02278965
Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether it is feasible to give a combination of Metformin and omega-3 fatty acids for one year to women with a history of early stage breast cancer. We will also evaluate whether the metformin and omega-3 fatty acids combination causes changes in breast tissue, blood, and mammograms.
Timeline
- Start
- 2015-01-22
- Primary completion
- 2017-04-19
- Completion
- 2017-04-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 850 mg | Oral |
| Subject | Omega-3 fatty acids | Unknown | 1120 mg | Oral |